Operationalise: Early Access Programmes Europe

Early/Managed/Expanded access programmes in Europe have varying legislations Prices: Drug Developers | Conf. + 3 Workshops: £3896.00, Drug Developers | Conf. + 2 Workshops: £3397.00, Drug Developers | Conf. + 1 Workshop: £2898.00, Drug Developers | Conf. only: £2399.00, Solution Provider | Conf. + 3 Workshops: £4646.00, Solution Provider | Conf. + 2 Workshops: £4097.00, Solution Provider | Conf. + 1 Workshop: £3548.00, Solution Provider | Conf. only: £2999.00

Share this event:

Speakers

Alita Hassan | Vice President | Early Access Care, Amber Fisher | Clinical Research Manager | Kura Oncology, Anna Litsiou | Regulatory Policy and Intelligence Director - International & China | AstraZeneca, Anne Cropp | Chief Scientific Officer | Early Access Care, Annie Drelles | Director & Head of Office of Medical Access, Global Oncology & Medical Affairs | Daiichi Sankyo, Inc., and more

Location

Hilton London Canary Wharf Marsh Wall London E14 9SH

Nearby events